Načítá se...
Udenafil: efficacy and tolerability in the management of erectile dysfunction
Udenafil is a potent novel phosphodiesterase-5 inhibitor approved for use in Korea. Udenafil has unique properties, with a T (max) of 1.0–1.5 h and a T (1/2) of 11–13 h (a relatively rapid onset and a long duration of action). Therefore, both on-demand and once-daily use of udenafil have been report...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3607490/ https://ncbi.nlm.nih.gov/pubmed/23554845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287212470019 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|